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ABSTRACT
In this article we report the in vivo and in vitro
characterization of single chain tetracycline repres-
sor (scTetR) variants in Escherichia coli. ScTetR
is genetically and proteolytically stable and exhibits
the same regulatory properties as dimeric TetR
in E.coli. Urea-dependent denaturation of scTetR
is independent of the protein concentration and
follows the two-state model with a monophasic
transition. Contrary to dimeric TetR, scTetR allows
the construction of scTetR mutants, in which one
subunit contains a defective inducer binding site
while the other is functional. We have used this
approach to establish that scTetR needs occupation
of both inducer binding sites for in vivo and in vitro
induction. Single mutations causing loss of induc-
tion in dimeric TetR lead to non-inducible scTetR
when inserted into one half-side. The construction
of scTetR H64K S135L S138I (scTetR
i2) in which
one half-side is specific for 4-dedimethylamino-
anhydrotetracycline (4-ddma-atc) and the other for
tetracycline (tc) leads to a protein which is only
inducible by the mixture of tc and 4-ddma-atc. Fluor-
escence titration of scTetR
i2 with both inducers
revealed distinct occupancy with each of these
inducers yielding roughly a 1:1 stoichiometry of
each inducer per scTetR
i2. The properties of this
gain of function mutant clearly demonstrate that
scTetR requires the binding of two inducers for
induction of transcription.
INTRODUCTION
Gene regulation in bacteria occurs mostly at the level of
transcription mediated by DNA binding proteins like activat-
ors or repressors (1). Most of them are homodimers, as was
demonstrated for members of the LacI/GalR, TetR/CamR,
FadR, MerR or LysR families (2–4). They exert their regulat-
ory function by binding effectors upon which a conforma-
tional change is triggered which allosterically affects DNA
binding.
The bacterial tetracycline (tc) responsive repressor, TetR,
exhibits high afﬁnity (5.6 ± 2 · 10
9 M
 1) for the tet operator
(tetO) and is very sensitive to induction by tc and its ana-
logues (5–10). These features combined with the capacity
of tc to penetrate cell membranes by passive diffusion have
led to its wide use as a tool for gene regulation in prokaryotes
and eukaryotes (11–14). Crystal structures of TetR revealed
that two identical subunits each consisting of 10 a-helices
form the active homodimer. Two DNA reading heads are
connected to a core domain in which dimerization takes
place and which harbours two inducer binding pockets. The
[tc–Mg]
+ complex binds into each pocket and triggers a
movement of helix 6 which is transferred via helices 4 and
1 to the DNA binding heads (9,15) moving them apart by
 3 s. As a consequence, the afﬁnity to the tetO is lowered
by four orders of magnitude (16) and TetR leaves the DNA.
When bound to TetR, each [tc–Mg]
+ complex is contacted
by 13 residues from 1 monomer and 4 from the other. Since
one inducer contacts residues from both subunits it is
conceivable that the allosteric change may be triggered by
binding of a single tc molecule. There is only very little
information available regarding the correlation between the
number of occupied inducer binding sites necessary for
induction in regulatory proteins. This has been discussed
for MerR, a member of the MerR/SoxR family (17) involved
in the regulation of bacterial mercury resistance. Preliminary
data would be in agreement with induction by binding of one
Hg
+ to the MerR dimer (18,19). The multi-drug resistance rep-
ressor QacR is, like TetR, a member of the TetR/CamR fam-
ily of regulators (20). In vitro binding studies revealed a 1:2
stoichiometry of inducer per QacR dimer, and it has been
suggested that this is sufﬁcient for induction in vivo (21).
Addressing this question in vivo is generally hampered by
the exchange of subunits in a dimer as has been clearly
demonstrated for TetR (7). Thus, a strain containing a wild
type and an induction deﬁcient allele of tetR would contain
a mixture of all three possible dimers.
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in which the two subunits of TetR are linked by a 25 amino
acids (SG4)5 sequence and cannot form heterodimers (22),
and their use to construct and analyze TetR variants with
mutations in just one half-side in Escherichia coli. We estab-
lish clearly, that TetR needs to bind two inducers to accom-
plish induction.
MATERIALS AND METHODS
General materials and methods
Anhydrotetracycline (atc) was purchased from Acros (Geel,
Belgium). All other chemicals were from Merck (Darmstadt,
Germany), Roth (Karlsruhe, Germany) or Sigma (Munich,
Germany) at the highest purity available. Enzymes for
DNA restriction and modiﬁcation were from New England
Biolabs (Frankfurt/Main, Germany) or Roche (Mannheim,
Germany). Isolation and manipulation of DNA as well as
strain transformation was performed as described previously
(23). All plasmids constructed were sequenced between the
restriction sites employed for cloning. Oligonucleotides for
PCR and sequencing were obtained from MWG Biotech
(Ebersberg, Germany) unless stated otherwise. Sequencing
was carried out according to the protocol provided by
Applied Biosystems for cycle sequencing and analyzed with
an ABI PRISM 310 Genetic Analyzer (Applied Biosystems,
Weiterstadt, Germany). For b-galactosidase (b-gal) assays,
E.coli WH207ltet50 bearing a Tn10 tetA–lacZ trancriptional
fusion was used. Cells were grown in Luria–Bertani (LB)
medium supplemented with the required antibiotics to an
OD600 of 0.4. b-gal activity was determined as published
previously (24).
Culture and growth conditions
E.coli was generally grown in LB medium at 37 C. Antibiot-
ics for selection were added to the following ﬁnal concentra-
tions: Ampicillin (Ap) 100 mg/l, Kanamycin (Kan) 30 mg/l.
When necessary, the cultures were adjusted to ﬁnal concen-
trations of atc, tc or 4-dedimethylamino-anhydrotetracycline
(4-ddma-atc) as indicated. All atc and 4-ddma-atc solutions
were protected from light. Tc and atc were dissolved in
70% ethanol, 4-ddma-atc was solved in dimethyl sulfoxide.
Design and construction of genes and plasmids
Components for construction of scTetR. The following DNA
fragments were already available: wt-tetR(BD) and a (SG4)5
encoding linker sequence together with the ﬁrst 50 codons
of the synthetic tetR(B) sequence (termed tetR(sB) origina-
tiong from sctetR(BsB) (22). TetR(BD) is a chimera consist-
ing of the ﬁrst 50 codons of tetR(B) fused to the last 158
codons of tetR(D).
We designed the DNA sequence of the synthetic class (D)
portion de novo by in silico back-translation of the primary
protein sequence online at http://www.entelechon.com/eng/
backtranslation.html. Settings were attuned to human codon
usage and putative eukaryotic splicing-sites were eliminated.
For use in E.coli rare arginine codons were silently exchan-
ged (as found at www.kazusa.or.jp/codon). Care was taken
that the length of identical DNA stretches to tetR(BD) did
not exceed 20 bp to minimize recombination events (25). The
ﬁnal sequence of sctetR(BDsBsD) was deposited in the NCBI
GenBank (accession no. DQ 392985). A total of 20 oligo-
nucleotides, 39–48 bp in length (MWG Biotech, Ebersberg,
Germany), entirely covering both strands of the desired
‘tetR(D) gene fragment (471 bp in size), with an overlap of
12 bp to complementary oligos were used. Assembling was
done in a PCR-like method, as described previously (26). A
DNA-sequence alignment of the gene portions ‘tetR(D)’
and ‘tetR(sD)’ displayed an identity of  76%. The assembled
product was ampliﬁed with primers syn(D)c_fw1 (50-ctagca-
gtcgagatactggcccggcaccatgactacagt-30) and syn(D)c_rev10
(50-catggcctcacacaatctgaaggagggctgtaagctgga-30) and tem-
porarily subcloned into pCR 2.1-Topo  (Invitrogen,
Karlsruhe, Germany) as recommended by the manufacturer.
Construction of scTetR(BDsBsD). Construction of
sctetR(BD) was performed in pWH1926 (like pWH1925
(6), however with tetR(BD) running in opposite direction).
The 30 end of tetR(BD) was modiﬁed by silently inserting a
ClaI restriction site upstream of the stop-codon (PCR primers
were sc0_fw and sc0_rev, restriction was done with MluI and
NcoI).
After ampliﬁcation and modiﬁcation by PCR using
primers sc1_fw (50-gtgaaagtatcgattcaggaggcggtgg-30) and
sc1_rev (50-gtatgatccatggccagcatctcgattgctagcgcatcgag-30),
the (SG4)5 linker sequence together with the ﬁrst 50 codons
of the synthetic tetR(sB) sequence was fused to the 30 end
of tetR(BD) via ClaI and NcoI, simultaneously inserting a
new NheI site directly in front of NcoI. The tetR(sD) portion
of the pCRO 2.1-TopoO  derivative described above
was ﬁnally inserted as an NheI/NcoI fragment into
the likewise cut pWH1926 derivative, resulting in a
full-length sctetR(BDsBsD) gene, which gave rise to
pWH1926(BDsBsD). The gene was entirely sequenced on
both directions. Finally sctetR(BDsBsD) was cloned into a
pWH1925 derivative to enable exact comparison with other
variants, most of which are encoded on this vector. All tetR
and sctetR variants were cloned and analyzed as pWH1925
derivatives. For overexpression of wild-type scTetR, the
synthetic part was set in front of the gene. For the sake of
convenience all tetR(BD) genes and proteins are termed
tetR or TetR, while sctetR(BDsBsD) and the corresponding
protein are denoted sctetR or scTetR, respectively.
Lysozyme tratment of cells and western blot analysis
Cells from a 20 ml culture were harvested at an OD600 of
0.4 by centrifugation at 8000 r.p.m. at 4 C and the pellet
was resuspended in 500 ml buffer containing 10 mM Tris–
HCl (pH 8.0), 200 mM NaCl, 0.4 mM EDTA and 20 g/l
lysozyme. The lysate was incubated at ambient temperatures
for 60 min followed by centrifugation at 13000 r.p.m., 4 C
for 60 min. The protein concentration of the soluble fraction
was determined using the Biorad Assay (Bio-Rad Laborator-
ies, Munich, Germany). TetR was detected by SDS–PAGE
of 35 mg E.coli cell extract on a 10% polyacrylamide
gel. Proteins were transferred by electroblotting onto a
PhotoGeneO  nylon membrane (GibcoBRL, Karlsruhe,
Germany). Further steps were performed as described
previously (27).
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For overexpression we used the plasmid pWH610 and the
strain RB791. Proteins were puriﬁed as described previously
(28) except scTetR
i2, which was overproduced at 22 C. After
harvesting, cell pellets were stored on ice instead of freez-
ing. The temperature of all subsequent steps was kept
below 8 C.
Electrophoretic mobility shift assays and
fluorescence measurements
For electrophoretic mobility shift assays (EMSA), the com-
plementary synthetic 40 bases tetO containing oligo-
nucleotides designated tetO1 and tetO2 were hybridized.
Equimolar amounts of each oligonucleotide were mixed in
water, heated at 96 C for 5 min and allowed to cool to
room temperature within 2 h. A double stranded oligonuc-
leotide of the same size without palindromic sequence was
used as a control. TetR proteins were added at indicated
amounts. All samples were incubated in a complex buffer con-
taining 0.02 M Tris–HCl (pH 8.0) and 5 mM MgCl2. Atc and
4-ddma-atc were added to ﬁnal concentrations of 0.1 mM to
the sample. After incubation for 10 min at ambient temperat-
ures, the DNA was electrophoresed on an 8% polyacrylamide
gel at 50 V in TBM buffer (0.09 M Tris, 0.09 M boric acid
and 5 mM MgCl2), and the DNA was detected by ethidium
bromide staining. Fluorescence titrations were performed as
described previously (16) with excitation/emission wave-
lengths of 370/515 nm to observe tc- and 420/540 nm to
observe 4-ddma-atc-binding.
Denaturation of scTetR
All measurements were performed in F-buffer [100 mM
Tris–HCl (pH 7.5), 100 mM NaCl, 5 mM MgCl2,1m M
EDTA and 1 mM dithiothreitol]. Equilibrium denaturation
was carried out by incubation of protein samples overnight
at given urea concentrations. Protein samples which had
been incubated for 3 h at 20 C in F-buffer containing 8 M
urea, were renaturated by dilution them 200-fold in F-buffer
without urea. All measurements were performed at 25 C.
Fluorescence intensities were measured at an excitation
wavelength of 280 and 295 nm, respectively, emission intens-
ity was recorded at 324 nm and corrected by the substraction
of the buffer ﬂuorescence.
Thermodynamic calculations
For scTetR, a two-state model of denaturation was applied in
which a native monomeric protein N exists in equilibrium
with a denatured monomer, U:
N   U: 1
The equilibrium constant Ku for every measured point within
the linear transition was calculated according to two step
denaturation of a monomeric protein, in which fu is the frac-
tion of unfolded protein.
Ku ¼
½U 
½F 
¼
f u
ð1   f uÞ
: 2
The linear extrapolation method (33) was used to derive
protein stability at zero urea concentration.
DG
 
u ¼ DG
 
uðH2OÞ m½urea ¼  RT lnðKuÞ‚ 3
where DG
 
u stands for Gibbs free energy of unfolding at a 1 M
concentration of all reactants, DG
 
u (H2O) is the extrapolated
Gibbs free energy in buffer without urea and m represents the
slope of the straight line in the plot of DGu versus denaturant
concentration. At the midpoint of the unfolding transition at
urea1/2, DG
o ¼ 0 and Ku ¼ 1. To determine urea1/2,w e
rearranged Equation 3 to Equation 4.
½urea1/2 ¼
DG
 
uðH2OÞ
m
4
RESULTS
Construction and in vivo stability of scTetR
The scTetR variant was constructed as described for the
mammalian applications (22) except that a sequence variant
with optimal regulatory properties in bacteria was used (see
Figure 1). Since the in vivo properties of scTetR with muta-
tions in one inducer binding pocket may be masked by small
amounts of dimeric TetR which could result from recombina-
tion of the repeat tetR sequence or from proteolysis within the
peptide linker, it was important to exclude such events. To
minimize recombination, we constructed a synthetic tetR
allele (see Materials and Methods for details) so that the
DNA sequence identity is only  76%. Identical sequences
Figure 1. Schematic presentation of dimeric and scTetR mutants. The protein
arrangements possible with different genetic situations are shown. (A) The
TetR dimers arising from two different tetR alleles expressed in the same cell.
The filled star indicates a mutation. The three possible dimers are two
homodimers and one heterodimer. (B) The scTetR gene (sctetR) in which
one half-side carries the mutation (filled star). The first tetR sequence (white
arrow) contains the desired mutation (filled star), followed by the linker
encoding sequence designated (SG4)5 and the second synthetic tetR sequence
(grey arrow). The resulting monomeric protein contains the mutation (filled
star) in one half-side.
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bination. The genetic stability of the resulting sctetR in
E.coli DH5a harbouring pWH1925sctetR was determined
by growing at 37 C over night on LB/Ap plates. Colonies
were streaked out for three successive times and then used
to inoculate a liquid culture. Plasmids isolated from these
cultures gave restriction patterns indicating the presence of
only the full-length sctetR which was also conﬁrmed by
sequencing (data not shown).
The proteolytic stability of scTetR was examined by west-
ern blots. As presented in Figure 2, a single band of TetR at
 23 kDa is observed in extracts from cells containing tetR
after soniﬁcation or lysozyme treatment (lanes 2 and 5).
The scTetR band appears at  46 kDa in the extract from
the respective strain containing sctetR (lanes 3 and 6). A
smear of additional bands indicating fragmentation is visible
below the scTetR signal when cells are broken by soniﬁcation
(lane 3), while these are absent when cells are treated with
lysozyme (lane 6). Taken together, these results indicate that
scTetR exhibits sufﬁcient genetic and proteolytic stability
for functional analysis in vivo.
ScTetR with a single inducer binding site is induction
deficient
We constructed three scTetR variants, each with the single
mutation N82A or T103A or E147A in only one half-side.
The residues N82, T103 and E147 in TetR are essential
for tc and atc binding, and each mutation to A leads to induc-
tion deﬁciency of the respective TetR mutant (29,30). The
encoded scTetR proteins will thus contain one deﬁcient and
one functional inducer binding pocket (see Figure 1). The
inducibility of these half-side scTetR mutants was deter-
mined by b-gal measurements with and without tc or atc
(Figure 3A). b-gal expression in the absence of tetR deﬁnes
the 100% level (data not shown). TetR and all single chain
variants repress lacZ in the absence of inducer to <1%
(data not shown). Tc leads to 45 and 22%, while atc leads
to 92 and 78% induction of TetR and scTetR, respectively.
The three TetR variants carrying mutations in both subunits
(black bars) are only weakly inducible with the more efﬁcient
inducer atc, resulting in b-gal activities between 9 and 4%,
while the corresponding single chain half-side mutants are
inducible to  12%. All three TetR and scTetR half-side
mutants are not inducible with tc (values <1% b-gal activity;
not shown). Thus, the inactivation of one inducer binding site
in scTetR reduces induction to about the same level as the
elimination of both inducer binding sites.
To analyse TetR- and scTetR-tetO interactions in vitro,w e
puriﬁed scTetR N82A and performed EMSA (Figure 3B).
This mutant binds tetO similar to dimeric TetR (compare
lanes 1–3 with lanes 4–6) in the absence of effector, where
a 5-fold molar excess of protein is needed for complete bind-
ing of tetO. ScTetR N82A is not released from tetO upon
addition of atc, since no band of free tetO DNA is visible
in lane 7, while dimeric wild-type TetR is efﬁciently removed
from tetO by atc, and the free operator DNA appears in
lane 8. Neither dimer nor scTetR bind a control fragment
which contains no tetO sequence (data not shown). We
conclude that the in vitro results are consistent with the
Figure 2. Western blots of TetR and scTetR. The influence of different
cell disruption methods on the integrity of TetR proteins is shown. Soluble
proteins from crude cell extracts (35 mg) were loaded in lanes 1–6. Proteins
from E.coli WH207ltet50 cells carrying pWH1925DtetR were loaded in
lanes 1 and 4; proteins from cells carrying pWH1925 (tetR) were loaded in
lanes 2 and 5, and cells carrying pWH1925sc (sctetR) were loaded in lanes 3
and 6. Lane 7 contains 60 ng of purified TetR, and lane 8 contains 20 ng of
purified scTetR. The lysis methods employed are indicated below the
respective lanes.
Figure 3. Induction efficiencies of sctetR with mutations in one inducer
binding pockets. (A) b gal activities of E.coli WH207ltet50 transformed with
plasmids expressing tetR (black columns) or sctetR (white columns) with
mutations causing induction deficiency in tetR (designated N82A, T103A or
E147A) in one half-side are shown. The b gal activity in the absence of
tetR was  8000 Miller Units and was set to 100% (data not shown). b gal
activities in the absence of inducer were <1% for all variants (data not
shown). b gal expression in the presence of inducers is shown for 0.4 mMt c
and 0.4 mM atc as indicated in the figure. (B) EMSA with purified TetR and
scTetR N82A carrying a mutation in one inducer binding pocket are shown in
the insert. The compounds and the amounts present in the respective reaction
mixtures are listed in the table above the lanes. The positions of bands
corresponding to free (f) and complexed (c) DNA are indicated on the
right side.
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inducer binding pocket.
ScTetR variants with different half-side inducer
specificities
In order to investigate whether the lack of inducibility can be
restored, we constructed a scTetR variant with different
inducer speciﬁcities in each half-side. The TetR
i2 mutant
H64K S135L S138I is speciﬁcally induced by 4-ddma-atc
and not by tc or atc (31). We introduced these mutations
into one half-side of scTetR and expected the resulting vari-
ant to harbour two distinct inducer speciﬁcities combined in
one protein called scTetR
i2. The regulatory properties of
this mutant were determined by b-gal measurements with
tc, atc, 4-ddma-atc and combinations of them (Figure 4A).
b-gal expression in the absence of tetR deﬁnes the 100%
level (data not shown). ScTetR is not inducible with
4-ddma-atc, while b-gal activities in the presence of tc and
atc are  35 and 80%, respectively, regardless of the presence
of 4-ddma-atc. ScTetR
i2 is not inducible with tc, atc or
4-ddma-atc alone. Induction of 40% b-gal expression is
observed in the presence of tc and 4-ddma-atc, and induction
of 55% in the presence of atc and 4-ddma-atc. Although the
b-gal activities are not as high as those of scTetR in the pres-
ence of atc, scTetR
i2 is apparently induced in the presence of
both effectors. This is in agreement with in vitro results
obtained by EMSA (Figure 4B). ScTetR
i2 binds to tetO in
the absence of inducer (lanes 1–3), whereas the control
DNA is not bound (lane 4). The bulk of tetO remains
bound in the presence of atc or 4-ddma-atc, as indicated by
the strong complex band, and only a small amount of free
DNA is visible in the presence of atc (lane 5). No band rep-
resenting the complexed DNA is visible in the presence of
atc and 4-ddma-atc, and the band corresponding to free
tetO is more intense (lane 7). The free operator DNA appears
in lane 0. Bands migrating above the complex appear only in
lanes loaded with samples containing inducer and scTetR.
Their ﬂuorescence exhibits a different colour than the DNA
stained with ethidium bromide and they are visible in control
lanes where only scTetR and inducer without DNA have been
loaded (data not shown). We conclude that they originate
from the scTetR-inducer complex and visualize the well-
known tetracycline ﬂuorescence which is enhanced in
complex with TetR. These results clearly indicate that two
occupied binding pockets are required for induction.
Binding pockets with different specificities are bound
only by their cognate inducers
Distinct occupancy of the effector-speciﬁc binding pockets
with the respective inducers was assayed by ﬂuorescence
titration of puriﬁed scTetR
i2 ﬁrst with tc and subsequently
with 4-ddma-atc in the same cuvette (Figure 5A and B). As
shown in Figure 5A, tc binding to TetR can clearly be detec-
ted based upon the excitation/emission wavelengths speciﬁc
for tc. The subsequent addition of 4-ddma-atc leads to only
a small further change of ﬂuorescence intensity. An increase
in ﬂuorescence cannot be detected upon addition of tc when
observed at excitation/emission wavelengths speciﬁc for
4-ddma-atc (Figure 5B), although tc binds to the ﬁrst wild-
type binding pocket (cf. Figure 5A). Thus, the increase in
ﬂuorescence during the following addition of 4-ddma-atc
must result from binding of 4-ddma-atc in its respective bind-
ing pocket. We analyzed a concentration of 2 nmol of protein
harbouring 4 nmol of binding pockets. As shown in Figure 5,
the equivalence point occurs at 1.3 nmol of tc and 1.8 nmol of
4-ddma-atc. Thus, roughly half of the available inducer bind-
ing sites are occupied by each of the two effectors.
ScTetR stability
A bimolecular single transition denaturation reaction has
been shown for dimeric TetR (32,33), which was the basis
for the two-state model of unfolding. We investigated urea-
dependent denaturation of scTetR. Conformational changes
during denaturation were monitored by the ﬂuorescence of
W43 and W75, located in the helix–turn–helix motif and in
the core domain, respectively. The ﬂuorescence quantum
yield decreases in dependence of the urea concentration,
and the emission maximum is shifted from 342 to 363 nm
upon denaturation. Fluorescence emission was determined at
324 nm where the highest change in ﬂuorescence occurs
Figure 4. Induction efficiencies of scTetR harbouring different inducer
specificities. (A) b gal activities of E.coli WH207ltet50 transformed with
plasmids expressing sctetR or sctetR
i2 (H64K, S135L, S138I in one half-side)
are depicted. The b gal activity in the absence of tetR is  8000 Miller
Units and was set to 100% (not shown). Measurements were performed in
the absence and presence of 0.4 mM of each inducer as indicated in the figure.
(B) EMSA were performed with purified scTetR
i2 and the compounds and
amounts indicated in the table above the lanes. ‘Random’ refers to a non-tetO
containing DNA. The positions of bands corresponding to free (f) and
complexed (c) DNA are indicated on the right side.
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sigmoidal, monophasic decrease in ﬂuorescence which is
independent of the scTetR concentration (Figure 6B). Thus,
there is no indication for any stable intermediate, indicating
that scTetR also denatures in an all or none process.
The midpoint of transition is not dependent on the protein
concentrations between 0.4 and 5 mM of scTetR (Table 1),
and the determination of urea1/2 (Equation 4) concentrations
yields values of 4.7, 4.7 and 4.8 M urea for 0.4, 1 and 5 mM
scTetR, respectively (Table 1). Since the transition is not
dependent on protein concentration, Gibbs free energy was
calculated employing Equation 2. The DG
 
u (H2O) values
determined by Equation 3 for each scTetR concentration
are identical within the standard deviations and range from
26 to 27 kJ/mol (Table 1).
DISCUSSION
We have constructed a bacterial scTetR and characterized the
modiﬁed protein in vivo and in vitro. Since TetR mutations
always occur in each subunit of the native dimer, we have
not been able up to now to determine whether induction
requires occupation of one or both inducer binding pockets.
We have overcome this limitation by ‘monomerizing’ TetR
to scTetR (Figure 1). The sctetR gene is genetically as stable
and the encoded protein is as functional in E.coli as dimeric
TetR. Apparently, the human codon usage implemented into
the synthetic part of sctetR did not notably reduce the trans-
lational efﬁciency in E.coli. It is surprising that this is pos-
sible with the (SG4)5 linker without any loss of activity. In
fact, we consistently observed a slightly increased repression
exerted by scTetR compared with the dimer (data not shown),
and induction is slightly impaired, which is probably due to
an increased amount of intracellular scTetR compared with
dimeric TetR (Figure 2). Another reason could be the
de facto duplication of the tetR gene dosis in sctetR. Although
the linker length was chosen to be long and ﬂexible enough
to allow assembly of both domains properly (22), it could
inﬂuence the entrance of inducer into the binding pocket.
However, increased regulatory effects have also been
Figure 5. Titration of scTetR
i2 with tc and 4-ddma-atc. (A) The fluorescence
intensity of 2 nmol of purified scTetR
i2 titrated with up to 8.5 nmol of tc
(corresponding to a concentration of 8.5 mM) followed by titration with up to
8.5 nmol of 4-ddma-atc (corresponding to a concentration of 8.5 mM) is
shown. Since fluorescence was excited at 370 nm and emission was measured
at 515 nm only the binding of tc to the protein is detected. (B) The same
experiment except that the excitation and emission wavelengths were 420 and
540 nm, repectively, where only 4-ddma-atc binding is observed. The
equivalence points are indicated by the dotted lines.
Figure 6. Urea-dependent denaturation of scTetR. (A) Fluorescence spectra
of native (solid line), denatured (long-dashed line) and renatured (dashed–
dotted line) scTetR are shown. The difference spectrum between native and
denatured forms is shown by the dotted line. (B) The figure shows the change
of fluorescence in dependence of the urea concentration. The fluorescence in
the absence of urea was set to 100% of folded protein. The denaturation
curves were determined at different concentrations of scTetR (filled triangle,
5 mM; circle, 1 mM; open triangle, 0.4 mM, scTetR).
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ryotes (22). Other dimeric repressors, like lambda Cro, P22
Arc or the N-terminal domains of the bacteriophage 434
repressor cI have been successfully modiﬁed such that they
are also expressed as a single chain protein to investigate
their stability and DNA binding (34–36). However, the
allosterical conformational change occurring upon effector
binding has to our knowledge not yet been analyzed in a
transcriptional regulator.
To clarify if one or two occupied binding pockets are
necessary for induction, we introduced three different muta-
tions conferring a non-inducible phenotype owing to lack of
inducer binding into one half-side of scTetR. The respective
dimeric TetR mutants exhibit a massive drop of inducer
afﬁnity (29,30). We assume that they exert a similar inﬂuence
on the respective scTetR half-side containing the alteration.
Indeed, half-side induction deﬁcient mutants are efﬁcient
non-inducible repressors as demonstrated in vivo and
in vitro (Figure 3). While the tetO binding clearly under-
scores that the half-side mutant proteins are functional, the
lack of induction is nevertheless a negative result, and
could thus be attributed to local folding problems around
the inducer binding pocket.
To obtain a gain of function mutation we have examined
the inducibility of scTetR with two different effector spe-
ciﬁcities harbored in both half-sides. The TetR
i2 protein
shows speciﬁcity for 4-ddma-atc (5) in one half-side and
for tc or atc in the other. As a result, scTetR
i2 is only
inducible by mixtures of tc/4-ddma-atc or atc/4-ddma-atc.
This clearly points out that (i) both binding pockets need to
be occupied with suitable inducers to lead to the allosteric
conformational change necessary for induction and (ii) both
half-sides are folded properly and are active. EMSA and tc-
and 4-ddma-atc-dependent titrations veriﬁed the distinct
occupancy of the two binding pockets by the suitable inducer
as well as a 1:2 stoichiometry for each of them. Furthermore,
the titrations demonstrate that the respective speciﬁcities of
the binding pockets, although each binding pocket is formed
by residues of both monomers, are totally independent on its
counterpart’s sequence and speciﬁcity (Figure 5).
Despite the participation of residues of both monomers in
binding of one inducer, it is not likely in the light of the crys-
tal structure (9) that the second monomer undergoes major
conformational changes when the [tc–Mg]
+ complex binds
to the pocket mainly formed by the other monomer. Hence,
a suitable movement of both binding heads requires the allos-
teric process to occur in both half-sides. It is shown here that
this requires occupation of both binding pockets. It is not
clear whether induction by different effectors in both half-
sides differs from that of wild-type TetR. As shown for
another homodimeric repressor, LacI (37), an asymmetric
mechanism of induction could be possible.
The TetR family of bacterial regulators is mainly deﬁned
by sequence similarities in the DNA reading heads (20).
Hence it is conceivable that members of this diverse family
may follow different induction modes. This seems to be the
case for TetR requiring two inducers bound per dimer and
QacR, for which one inducer bound per dimer seems to be
sufﬁcient for induction. One possibility would be that TetR
contacts tetO more strongly than QacR binds its respective
cognate DNA. In addition, there is a very remarkable differ-
ence in DNA binding between the two repressors, as QacR
uses a tetramer to bind its operator (21). Hence, there might
also be a very different allosteric process underlying induc-
tion. Given the lack of sequence similarity within the inducer
binding regions of the TetR family proteins, there might be a
number of more different induction pathways present in this
family.
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